Coxsackievirus B3 Susceptibility C1861511
A genetic tendency to be more vulnerable to Coxsackievirus B3, a virus that can cause infections affecting the heart, brain, and skin in some people.
Key facts at a glance
- ICD-10
- R69
- ICD-11
- MA00.0
- Body system
- immunologic
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Fever
(general)Generalized symptoms
(immunologic)Mild symptoms that may not significantly impact daily life.
Frequency: Common at all stages
Sore throat
(ENT)Rash
(dermatologic)Fatigue
(general)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Healthy lifestyle changes and stress management
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Infection Prevention Strategies
Implementation of rigorous hand hygiene, avoiding contact with infected individuals, and practicing food safety measures to minimize exposure to Coxsackievirus B3.
Cardiac Monitoring and Surveillance
Regular electrocardiograms and echocardiograms to detect early signs of myocarditis or pericarditis, which are common complications of Coxsackievirus B3 infection.
Additional treatment options
Supportive Cardiac Medications
Use of medications such as ACE inhibitors or beta-blockers to support cardiac function if myocarditis develops, along with anti-inflammatory agents when clinically indicated.
medicationImmunomodulatory Support
Nutritional support including vitamins and minerals that support immune function, though evidence for direct therapeutic benefit is limited.
complementaryAdvanced Cardiac Evaluation
Referral to cardiology for stress testing, cardiac MRI, or endomyocardial biopsy when initial monitoring suggests significant cardiac involvement.
procedureWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Coxsackievirus B3 Susceptibility C1861511?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Knowlton KU, Badorrek C. Coxsackievirus B3 and the pathogenesis of myocarditis: mechanisms of viral entry and immune response. Circ Res. 2019.
Ammirati E, Veronese G, Frigerio M, et al. Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy: An Expert Position Paper. Eur Heart J. 2020.
Pinkert S, Westermann D, Wang X, et al. Experimental therapy of coxsackievirus B3-infected mice with interferon-beta and captopril. J Mol Cell Cardiol. 2018.
Hia CP, Yeo KT, Khor CS. Enteroviral myocarditis in children: a systematic review and meta-analysis of clinical characteristics and outcomes. Pediatr Infect Dis J. 2022.
Medication Comparisons
Compare medications used to treat Coxsackievirus B3 Susceptibility C1861511. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy